| scholarly article | Q13442814 |
| P50 | author | Helen Håkansson | Q71007440 |
| P2093 | author name string | Aldert H Piersma | |
| Leo T M van der Ven | |||
| Theo J Visser | |||
| Aart Verhoef | |||
| Wout Slob | |||
| Pim E G Leonards | |||
| Maria Herlin | |||
| Timo Hamers | |||
| Josephus G Vos | |||
| Hanna Olausson | |||
| Ton van de Kuil | |||
| P2860 | cites work | Regulation of iodothyronine deiodinases in the Pax8-/- mouse model of congenital hypothyroidism | Q28584995 |
| Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro | Q31399638 | ||
| The thyroxine-binding proteins | Q33863834 | ||
| An overview of commercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of release | Q34212627 | ||
| The retinoid signaling system--a target in dioxin toxicity | Q34692833 | ||
| Risk assessment of thyroid follicular cell tumors | Q34939457 | ||
| Toxic effects of brominated flame retardants in man and in wildlife | Q35172736 | ||
| Are brominated flame retardants endocrine disruptors? | Q35172744 | ||
| The molecular actions of thyroid hormone in bone | Q35546577 | ||
| Functional protein-protein interaction of drug metabolizing enzymes | Q35966417 | ||
| Peripheral metabolism of thyroid hormone and glucose homeostasis | Q36244519 | ||
| Mechanistic data and risk assessment of selected toxic end points of the thyroid gland | Q36849669 | ||
| The analysis of organ weight data | Q36882432 | ||
| Impaired behaviour, learning and memory, in adult mice neonatally exposed to hexabromocyclododecane (HBCDD). | Q42729728 | ||
| Distribution and fate of HBCD and TBBPA brominated flame retardants in North Sea estuaries and aquatic food webs. | Q43317384 | ||
| Feasibility and potential gains of enhancing the subacute rat study protocol (OECD test guideline no. 407) by additional parameters selected to determine endocrine modulation. A pre-validation study to determine endocrine-mediated effects of the ant | Q43609150 | ||
| Temporal trend studies on tetra- and pentabrominated diphenyl ethers and hexabromocyclododecane in guillemot egg from the Baltic Sea. | Q44724026 | ||
| Modulation at a cellular level of the thyroid hormone receptor-mediated gene expression by 1,2,5,6,9,10-hexabromocyclododecane (HBCD), 4,4'-diiodobiphenyl (DIB), and nitrofen (NIP). | Q45178172 | ||
| Levels of hexabromocyclododecane in harbor porpoises and common dolphins from western European seas, with evidence for stereoisomer-specific biotransformation by cytochrome p450. | Q46472118 | ||
| Subacute effects of the brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on hepatic cytochrome P450 levels in rats | Q46834319 | ||
| Relationships between organ weight and body/brain weight in the rat: what is the best analytical endpoint? | Q47416285 | ||
| Dose-response modeling of continuous endpoints. | Q52044652 | ||
| A simulation study of the influence of study design on the estimation of benchmark doses for developmental toxicity. | Q52201383 | ||
| In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. | Q52569861 | ||
| Allometric analysis of organ weights. I. Rats | Q52857152 | ||
| The state-of-the-science and trends of brominated flame retardants in the environment: present knowledge and future directions. | Q53782989 | ||
| Polybrominated dibenzo-p-dioxins and dibenzofurans: the flame retardant issue | Q56431835 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 281-292 | |
| P577 | publication date | 2006-09-19 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | A 28-day oral dose toxicity study enhanced to detect endocrine effects of hexabromocyclododecane in Wistar rats | |
| P478 | volume | 94 |
| Q42850429 | 1,2,5,6,9,10-αHexabromocyclododecane (HBCD) impairs thyroid hormone-induced dendrite arborization of Purkinje cells and suppresses thyroid hormone receptor-mediated transcription. |
| Q36640291 | Acute effects of hexabromocyclododecane on Leydig cell cyclic nucleotide signaling and steroidogenesis in vitro |
| Q28390549 | Associations between brominated flame retardants in human milk and thyroid-stimulating hormone (TSH) in neonates |
| Q36873509 | Bone mineral density changes in relation to environmental PCB exposure |
| Q52585517 | Brominated flame retardants as possible endocrine disrupters. |
| Q34580183 | Brominated flame retardants, tetrabromobisphenol A and hexabromocyclododecane, activate mitogen-activated protein kinases (MAPKs) in human natural killer cells |
| Q89376636 | Complete genome sequence of Bacillus sp. HBCD-sjtu, an efficient HBCD-degrading bacterium |
| Q30514104 | Effects of chronic exposure to an environmentally relevant mixture of brominated flame retardants on the reproductive and thyroid system in adult male rats. |
| Q42710047 | Effects of low-level hexabromocyclododecane (HBCD) exposure on cardiac development in zebrafish embryos |
| Q38590683 | Endocrine disruptors and obesity |
| Q35448074 | Evaluation of arecoline hydrobromide toxicity after a 14-day repeated oral administration in Wistar rats |
| Q33569487 | Exposure to hexabromocyclododecanes (HBCDs) via dust ingestion, but not diet, correlates with concentrations in human serum: preliminary results |
| Q48194766 | Flame retardants, hexabromocyclododecane (HCBD) and tetrabromobisphenol a (TBBPA), alter secretion of tumor necrosis factor alpha (TNFα) from human immune cells. |
| Q56968360 | Gender specific differences in the liver proteome of rats exposed to short term and low-concentration hexabromocyclododecane (HBCD) |
| Q34160878 | Halogenated flame retardants: do the fire safety benefits justify the risks? |
| Q36619978 | Hexabromocyclododecane and tetrabromobisphenol A alter secretion of interferon gamma (IFN-γ) from human immune cells |
| Q37456902 | Hexabromocyclododecane decreases the lytic function and ATP levels of human natural killer cells |
| Q33876048 | Hexabromocyclododecane decreases tumor-cell-binding capacity and cell-surface protein expression of human natural killer cells |
| Q42709187 | Hexabromocyclododecane facilitates FSH activation of ERK1/2 and AKT through epidermal growth factor receptor in rat granulosa cells |
| Q42445985 | Hexabromocyclododecane inhibits depolarization-induced increase in intracellular calcium levels and neurotransmitter release in PC12 cells |
| Q58094813 | Hexabromocyclododecane: concentrations and isomer profiles from sources to environmental sinks |
| Q37627583 | Impaired lipid and glucose homeostasis in hexabromocyclododecane-exposed mice fed a high-fat diet |
| Q48302719 | Impairment in the mesohippocampal dopamine circuit following exposure to the brominated flame retardant, HBCDD. |
| Q57653743 | Kinetic study of γ-hexabromocyclododecane orally given to laying hens (Gallus domesticus) |
| Q87115241 | NMR- and LC-MS/MS-based urine metabolomic investigation of the subacute effects of hexabromocyclododecane in mice |
| Q47890353 | Neuroprotection by Taurine on HBCD-Induced Apoptosis in PC12 Cells |
| Q55893642 | POPs and Human Health Risk Assessment |
| Q47572573 | Parallel in vivo and in vitro transcriptomics analysis reveals calcium and zinc signalling in the brain as sensitive targets of HBCD neurotoxicity |
| Q51858088 | Perinatal exposure to environmental contaminants detected in Canadian Arctic human populations changes bone geometry and biomechanical properties in rat offspring. |
| Q36072551 | Policy relevant results from an expert elicitation on the human health risks of decabromodiphenyl ether (decaBDE) and hexabromocyclododecane (HBCD). |
| Q47150396 | Scientific Opinion on Hexabromocyclododecanes (HBCDDs) in Food |
| Q36366275 | Selective damage to dopaminergic transporters following exposure to the brominated flame retardant, HBCDD |
| Q37738907 | Serum Metabolomic Profiles in Neonatal Mice following Oral Brominated Flame Retardant Exposures to Hexabromocyclododecane (HBCD) Alpha, Gamma, and Commercial Mixture |
| Q39147874 | The cytological effects of HBCDs on human hepatocyte L02 and the potential molecular mechanism |
| Q37000039 | The fate of β-hexabromocyclododecane in female C57BL/6 mice |
| Q38992221 | The inadequacies of pre-market chemical risk assessment's toxicity studies-the implications. |
| Q57653661 | Tissue Distribution and Transfer to Eggs of Ingested α-Hexabromocyclododecane (α-HBCDD) in Laying Hens (Gallus domesticus) |
| Q28307982 | Toxicokinetics of the flame retardant hexabromocyclododecane alpha: effect of dose, timing, route, repeated exposure, and metabolism |
| Q28285713 | Toxicokinetics of the flame retardant hexabromocyclododecane gamma: effect of dose, timing, route, repeated exposure, and metabolism |
| Q48616126 | Transient aberration of neuronal development in the hippocampal dentate gyrus after developmental exposure to brominated flame retardants in rats. |
| Q46769407 | Uptake, distribution, depletion, and in ovo transfer of isomers of hexabromocyclododecane flame retardant in diet-exposed American kestrels (Falco sparverius). |
| Q42708207 | Use of an avian hepatocyte assay and the avian Toxchip Polymerse chain reaction array for testing prioritization of 16 organic flame retardants |
Search more.